These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6715608

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC, Werth VP.
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [Abstract] [Full Text] [Related]

  • 24. Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
    Arnson Y, Dovrish Z, Hadari R, Amital H.
    Isr Med Assoc J; 2007 Jun; 9(6):492-3. PubMed ID: 17642406
    [No Abstract] [Full Text] [Related]

  • 25. Refractory Cutaneous Dermatomyositis With Severe Scalp Pruritus Responsive to Apremilast.
    Charlton D, Moghadam-Kia S, Smith K, Aggarwal R, English JC, Oddis CV.
    J Clin Rheumatol; 2021 Dec 01; 27(8S):S561-S562. PubMed ID: 30801336
    [Abstract] [Full Text] [Related]

  • 26. Methotrexate and azathioprine treatment of childhood dermatomyositis.
    Jacobs JC.
    Pediatrics; 1977 Feb 01; 59(2):212-8. PubMed ID: 299938
    [Abstract] [Full Text] [Related]

  • 27. Methotrexate treatment of recalcitrant childhood dermatomyositis.
    Miller LC, Sisson BA, Tucker LB, DeNardo BA, Schaller JG.
    Arthritis Rheum; 1992 Oct 01; 35(10):1143-9. PubMed ID: 1418005
    [Abstract] [Full Text] [Related]

  • 28. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E.
    Ann Med Interne (Paris); 2001 Nov 01; 152(7):455-64. PubMed ID: 11965087
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Development of classic dermatomyositis rash years after diagnosis of juvenile polymyositis.
    Lieberman SM, Sherry DD.
    J Clin Rheumatol; 2009 Sep 01; 15(6):316-8. PubMed ID: 19734743
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rituximab as therapy for refractory polymyositis and dermatomyositis.
    Noss EH, Hausner-Sypek DL, Weinblatt ME.
    J Rheumatol; 2006 May 01; 33(5):1021-6. PubMed ID: 16541475
    [Abstract] [Full Text] [Related]

  • 34. Dermatomyositis with inclusion body myositis pathology.
    Layzer R, Lee HS, Iverson D, Margeta M.
    Muscle Nerve; 2009 Sep 01; 40(3):469-71. PubMed ID: 19623629
    [Abstract] [Full Text] [Related]

  • 35. Amyopathic dermatomyositis with plantar keratoderma responding to methotrexate therapy.
    Morrell TJ, Mortensen WS, Langley S.
    Cutis; 2017 Aug 01; 100(2):E20-E24. PubMed ID: 28961302
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Juvenile dermatomyositis: clinical profile and disease course in 25 patients.
    Shehata R, al-Mayouf S, al-Dalaan A, al-Mazaid A, al-Balaa S, Bahabri S.
    Clin Exp Rheumatol; 1999 Aug 01; 17(1):115-8. PubMed ID: 10084045
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis.
    Niakan E, Pitner SE, Whitaker JN, Bertorini TE.
    Neurology; 1980 Mar 01; 30(3):286-91. PubMed ID: 7189028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.